What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.
Our Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others.
Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families.
We are seeking a highly skilled and detail-oriented Statistical Programmer to join our team on a part-time contract basis. This role will support biometric initiatives by developing and validating statistical programs for data analysis, reporting and presentation. The ideal candidate will have strong experience in both SAS and R programming, and a solid understanding of clinical trial data standards and regulatory requirements. This position reports to the Senior Director, Biometrics and will collaborate closely with cross-functional teams including Biostatistics, Data Management, and Clinical Operations.
Responsibilities- Develop, validate, and/or maintain statistical programs using SAS or R to support clinical trial data analysis, reporting, and regulatory submissions.
- Generate CDISC-compliant datasets (SDTM and ADaM) and outputs including tables, listings, and figures (TLFs).
- Perform quality control checks of programs and outputs to ensure accuracy and compliance with internal standards and regulatory guidelines.
- Collaborate with biostatisticians to implement analysis plans and customize outputs for target audiences.
- Support programming deliverables for ongoing clinical studies, including interim analyses and final study reports.
- Participate in the review of statistical analysis plans (SAPs), TLF shells, and other study documentation.
- Contribute to process improvement initiatives and development of standard macros and programming best practices.
- Communicate and escalate risks or issues related to programming deliverables in a timely manner
At Entrada, our passion for science, our devotion to patients and our values drives our behavior:
- Humanity - We genuinely care about patients and about one another.
- Tenacity - We are relentless and persistent in the pursuit of developing therapies for patients.
- Creativity - We are creative problem solvers.
- Collaboration - We are more than the sum of our parts.
- Curiosity - We have a growth mindset and push conventional thought and theory.
To thrive on our team, you will need to come with:
- Bachelor’s or Master’s degree in Statistics, Computer Science, or a related scientific discipline.
- Minimum 5 years of experience in clinical programming within the pharmaceutical, biotech, or CRO industry.
- Proficiency in SAS (Base, Macro, Graph) or R programming is required.
- Strong understanding of CDISC standards (SDTM, ADaM) and experience with electronic data capture (EDC) systems and integration of data from multiple sources.
- Familiarity with ICH GCP guidelines and regulatory submission requirements.
- Experience with rare disease therapeutic areas is a plus.
- Excellent problem-solving skills and attention to detail.
- Strong verbal and written communication skills.
- Ability to work independently and manage multiple priorities in a remote setting.
- This is a US-based remote, part-time contract position with flexible hours averaging ~ 10 hours per week. Occasional travel to Entrada’s Boston headquarters may be required.#LI-JF1 #LI-Remote
Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.
Third Party Staffing AgenciesEntrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes.
Privacy StatementEntrada Therapeutics, Inc. (the “Entrada,” “we,” “us,” or “our”) respects your privacy and we want you to be familiar with how we collect, use, share, or otherwise process, your Personal Information. Please reference our privacy statement here to understand how and when your data is being used.
Top Skills
Entrada Therapeutics Boston, Massachusetts, USA Office
6 Tide St, Boston, MA, United States, 02210
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
